Choosing a Midline Catheter
5 Things to Consider
By: Health Line Marketing—March 2018
1. Consider infusate characteristics in conjunction with anticipated duration of treatment (eg, 1-4 weeks.)
2. Consider a midline catheter for medications, and solutions, such as antimicrobials, fluid replacement, and analgesics with characteristics that are well tolerated by peripheral veins.
3. Do not use midline catheters for continuous vesicant therapy, parenteral nutrition, or infusates with an osmolarity greater than 900 mOsm/L.
4. Use caution with intermittent vesicant administration due to risk of undetected extravasation. The administration of vancomycin for less than 6 days through a midline catheter was found to be safe in one study.
5. Avoid the use of a midline catheter when the patient has a history of thrombosis, hypercoagulability, decreased venous flow to the extremities, or end-stage renal disease requiring vein preservation.
Source: Journal of Infusion Nursing Volume 39,Number 1S
Health Line International Corp. is not responsible for any errors, omissions, injury, loss, or damage arising from or relating to the use (or misuse) of any information, statements, or conclusions contained in or implied by the contents of this document or any of the source materials.
Using PICCs in Cancer Patients
By: Health Line Sales and Marketing -January 2017
A study completed comparing the safeness and effectiveness of using Health Line peripherally inserted central catheters (PICCs) in place of central venous catheters for various cancer treatments confirms PICCs are a “safe venous device for chemotherapy delivery.”
Synergy CT PICC lines were implanted into a total of 291 cancer patients receiving “chemotherapy and/or associated supportive nutritional therapy at fixed intervals of time” depending on the patient.
The study was done from January 1, 2012, to June 1, 2014, and concluded,
PICCs can be considered safe and reliable to deliver chemotherapy in particular during the early 2-3 months after implant. Nevertheless, physicians must be aware that failure may over in almost 15% of them, thus potentially overcoming the majority of PICC claimed advantages. Chemotherapy patients with risk factors with failure, in particular, previous DVT of the necessity of larger than 5F catheters, should be considered for an alternative vascular access device.”
For access to the full article, contact one of Health Line’s representatives.
Source: Sergio Bertogliom Beatrice Faccini, Luca Lallo, Ferdinando Cafiero and Paolo Bruzzi. "Peripherally Inserted Central Catheters (PICCs) in Cancer Patients Under Chemotherapy: A Prospective Study on the Incidence of Complications and Overall Failures." Journal of Surgical Oncology, 2016 (1-7).
Effectively Engage Customers:
By: Health Line Sales and Marketing- July 2016
Ask the right questions:
• Are you currently placing catheters? If so what types?
• How many catheters are you placing in a week/month?
• What catheter do you currently use (get the brand and part number)?
• What do you like about the catheter and kit you use?
• What would you change about your current catheter?
• Do you insert your catheters over-the-wire?
Get competitive pricing if possible.
If a customer says our price is high, it is usually not! Have the customer give you a list of the components in the competitor’s kit. Normally if the competitor has a lower price it is because they have very few components compared to Health Line standard kits. Tell the customer we can quote equivalent kits to the competitor with fewer components.
Sell the customer on complete kits:
• Health Line‘s complete kit prices are a substantially better than a competitor's complete kit price and only minimally higher than the competitor’s basic kits.
• The Health Line kit simply offers a greater value while maintaining equivalent therapy options.
Comparing Tapered and Non-tapered Catheters
By: Health Line Sales and Marketing- October 2016
There is much debate concerning catheters encompassing a “tapered” effect and if it is more or less effective in terms of avoiding thrombosis in the vein.
In the 2016 INS Guidelines it states:
Reverse taper on the hub end of the catheter, resulting in the largest outer diameter being inserted into the smallest vein diameter, is thought to be a contributing factor (top DVT). However, 1 comparison study between tapered and non-tapered PICCs could not find a difference between the catheter design, although the rate for both catheters was high. Trimming a PICC to a patient-specific length can result in the largest diameter of a reverse-tapered PICC inserted into the vein and has been suggested as a factor in DVT. 1,7,9-13 (I)
Therefore, when considering tapered and non-tapered catheters, catheter maintenance should take precedence over catheter design/features.”
Health Line Tips and Tricks for your Practice:
By: Health Line Sales and Marketing- April 2016
6 Signs You Shouldn’t Place a PICC Line
Complications from placing PICC lines are common, but if you know exactly when not to place a line, you will significantly reduce infections and complications.
Here are 6 signs you should NOT place a PICC line in your patient.
1. The presence of device related infection, bacteremia, or septicemia is known or suspected.
2. The patient's body size is insufficient to accommodate the size of the implanted device.
3. The patient is known or is suspected to be allergic to materials contained in the device.
4. There has been past irradiation of prospective insertion site.
5. There have been previous episodes of venous thrombosis or vascular surgical procedures at the prospective placement site.
6. There are local tissue factors that may prevent proper device stabilization and/or access.